JP2011528222A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011528222A5 JP2011528222A5 JP2011517723A JP2011517723A JP2011528222A5 JP 2011528222 A5 JP2011528222 A5 JP 2011528222A5 JP 2011517723 A JP2011517723 A JP 2011517723A JP 2011517723 A JP2011517723 A JP 2011517723A JP 2011528222 A5 JP2011528222 A5 JP 2011528222A5
- Authority
- JP
- Japan
- Prior art keywords
- rsv
- polypeptide
- chimeric
- amino acid
- immunogenic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8188808P | 2008-07-18 | 2008-07-18 | |
| US61/081,888 | 2008-07-18 | ||
| PCT/CA2009/001021 WO2010006447A1 (en) | 2008-07-18 | 2009-07-17 | Chimeric respiratory syncytial virus polypeptide antigens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011528222A JP2011528222A (ja) | 2011-11-17 |
| JP2011528222A5 true JP2011528222A5 (enExample) | 2012-09-06 |
Family
ID=41549978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011517723A Pending JP2011528222A (ja) | 2008-07-18 | 2009-07-17 | キメラ呼吸器合胞体ウイルスポリペプチド抗原 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20110177117A1 (enExample) |
| EP (1) | EP2324062A4 (enExample) |
| JP (1) | JP2011528222A (enExample) |
| KR (1) | KR20110045008A (enExample) |
| CN (1) | CN102131830A (enExample) |
| AU (1) | AU2009270399A1 (enExample) |
| BR (1) | BRPI0915960A2 (enExample) |
| CA (1) | CA2731194A1 (enExample) |
| EA (1) | EA201170217A1 (enExample) |
| IL (1) | IL210493A0 (enExample) |
| MX (1) | MX2011000668A (enExample) |
| WO (1) | WO2010006447A1 (enExample) |
| ZA (1) | ZA201100132B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5711972B2 (ja) * | 2007-12-24 | 2015-05-07 | アイディー バイオメディカル コーポレイション オブ ケベック | 組換えｒｓｖ抗原 |
| PT2445526T (pt) | 2009-06-24 | 2016-08-16 | Glaxosmithkline Biologicals Sa | Antigénios de rsv recombinantes |
| PL3178490T3 (pl) | 2009-07-15 | 2022-08-01 | Glaxosmithkline Biologicals S.A. | Kompozycje białka f rsv i sposoby ich wytwarzania |
| DK2590675T3 (en) | 2010-07-07 | 2018-10-29 | Artificial Cell Tech Inc | ANTI-ANTI-COMPOSITIONS AND PROCEDURES FOR RESPIRATORY SYNCYTIAL VIRUS |
| KR20140026392A (ko) * | 2011-03-02 | 2014-03-05 | 노파르티스 아게 | 저용량의 항원 및/또는 보조제를 갖는 조합 백신 |
| ES2651143T3 (es) | 2011-05-13 | 2018-01-24 | Glaxosmithkline Biologicals Sa | Antígenos de F de prefusión del VRS |
| WO2014144756A1 (en) * | 2013-03-15 | 2014-09-18 | Vlp Biotech, Inc. | Palivizumab epitope-based virus-like particles |
| KR102201555B1 (ko) * | 2013-04-15 | 2021-01-12 | 얀센 백신스 앤드 프리벤션 비.브이. | Ｒｓｖ ｇ 단백질에 결합하는 인간 항체 |
| JP6412107B2 (ja) | 2013-04-15 | 2018-10-24 | ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． | Ｒｓｖｇタンパク質に結合するヒト抗体 |
| EP2873708B1 (de) | 2013-11-19 | 2019-02-13 | Artimelt AG | Klebstoffzusammensetzung |
| MY205060A (en) | 2015-12-23 | 2024-09-30 | Pfizer | Rsv f protein mutants |
| EP3411712B1 (en) | 2016-02-03 | 2025-11-19 | CG Discovery, Inc. | Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites |
| US10063211B2 (en) * | 2016-02-03 | 2018-08-28 | Qualcomm Incorporated | Compact bypass and decoupling structure for millimeter-wave circuits |
| CN108265079A (zh) * | 2017-01-02 | 2018-07-10 | 刘昕 | 一种新型呼吸道合胞体病毒pre-F融合蛋白载体的制备方法 |
| WO2020175660A1 (ja) | 2019-02-28 | 2020-09-03 | Ｋｍバイオロジクス株式会社 | Ｒｓｖ ｆ／ｇキメラワクチン |
| CN114685627A (zh) * | 2020-12-28 | 2022-07-01 | 广州更新生物医药科技有限公司 | 一种预防呼吸道合胞病毒的rAAV载体疫苗 |
| WO2025026448A1 (zh) * | 2023-08-03 | 2025-02-06 | 广州穗和生物技术有限公司 | 修饰的呼吸道合胞病毒f蛋白及其用途 |
| WO2025263563A1 (ja) * | 2024-06-20 | 2025-12-26 | Ｋｍバイオロジクス株式会社 | ＲＳＶ ＦＧキメラｍＲＮＡワクチン |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4436727A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| US4866034A (en) * | 1982-05-26 | 1989-09-12 | Ribi Immunochem Research Inc. | Refined detoxified endotoxin |
| US5149650A (en) * | 1986-01-14 | 1992-09-22 | University Of North Carolina At Chapel Hill | Vaccines for human respiratory virus |
| US4877611A (en) * | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
| US5057540A (en) * | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| DE3878468T2 (de) * | 1987-12-23 | 1993-06-09 | Upjohn Co | Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus. |
| US4912094B1 (en) * | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| NZ253137A (en) * | 1992-06-25 | 1996-08-27 | Smithkline Beecham Biolog | Vaccine comprising antigen and/or antigenic composition, qs21 (quillaja saponaria molina extract) and 3 de-o-acylated monophosphoryl lipid a. |
| EP0689454B2 (en) * | 1993-03-23 | 2005-02-23 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| FR2718452B1 (fr) * | 1994-04-06 | 1996-06-28 | Pf Medicament | Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation. |
| DE122007000087I1 (de) * | 1998-10-16 | 2008-03-27 | Glaxosmithkline Biolog Sa | Adjuvanzsysteme und impfstoffe |
| US20040161846A1 (en) * | 2000-11-22 | 2004-08-19 | Mason Anthony John | Method of expression and agents identified thereby |
| US7368537B2 (en) * | 2003-07-15 | 2008-05-06 | Id Biomedical Corporation Of Quebec | Subunit vaccine against respiratory syncytial virus infection |
| FR2873378A1 (fr) * | 2004-07-23 | 2006-01-27 | Pierre Fabre Medicament Sa | Complexes immunogenes, leur procede de preparation et leur utilisation dans des compositions pharmaceutiques |
| JP5711972B2 (ja) * | 2007-12-24 | 2015-05-07 | アイディー バイオメディカル コーポレイション オブ ケベック | 組換えｒｓｖ抗原 |
-
2009
- 2009-07-17 AU AU2009270399A patent/AU2009270399A1/en not_active Abandoned
- 2009-07-17 JP JP2011517723A patent/JP2011528222A/ja active Pending
- 2009-07-17 WO PCT/CA2009/001021 patent/WO2010006447A1/en not_active Ceased
- 2009-07-17 MX MX2011000668A patent/MX2011000668A/es active IP Right Grant
- 2009-07-17 CA CA2731194A patent/CA2731194A1/en not_active Abandoned
- 2009-07-17 KR KR1020117003662A patent/KR20110045008A/ko not_active Withdrawn
- 2009-07-17 CN CN2009801332745A patent/CN102131830A/zh active Pending
- 2009-07-17 EP EP09797331A patent/EP2324062A4/en not_active Withdrawn
- 2009-07-17 BR BRPI0915960A patent/BRPI0915960A2/pt not_active IP Right Cessation
- 2009-07-17 EA EA201170217A patent/EA201170217A1/ru unknown
- 2009-07-17 US US13/054,651 patent/US20110177117A1/en not_active Abandoned
-
2011
- 2011-01-05 ZA ZA2011/00132A patent/ZA201100132B/en unknown
- 2011-01-06 IL IL210493A patent/IL210493A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528222A5 (enExample) | ||
| US12364749B2 (en) | RSV F protein mutants | |
| USRE47471E1 (en) | Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions | |
| CA2187083C (fr) | Fragment peptidique de la proteine g du virus respiratoire syncytial, agent immunogene, composition pharmaceutique le contenant et procede de preparation | |
| JP2010522540A5 (enExample) | ||
| JP7385680B2 (ja) | 変異型ｒｓｖ ｆタンパク質及びその利用 | |
| JP2012530761A5 (enExample) | ||
| HRP20161353T1 (hr) | Rekombinantni rsv antigeni | |
| RU2014117068A (ru) | Вакцина на основе рекомбинантных наночастиц f из rsv против респираторно-синцитиального вируса | |
| FI2970398T3 (fi) | Rsv f -prefuusioproteiineja ja niiden käyttö | |
| JP2011500035A5 (enExample) | ||
| JP2010508030A5 (enExample) | ||
| JP2015509707A5 (enExample) | ||
| EP3638284B1 (en) | Cyclic peptides for protection against respiratory syncytial virus | |
| JP7146926B2 (ja) | Ｃｄ４ヘルパーｔ細胞エピトープの融合ペプチドおよびそのワクチン | |
| WO2015165480A1 (en) | Human cytomegalovirus vaccine compositions and method of producing the same | |
| CN113769080B (zh) | 多肽免疫偶联物及其应用 | |
| WO2011153959A1 (zh) | 流感病毒m2或ha片段与蛋白载体的缀合物及其制药应用 | |
| JP2010535504A5 (enExample) | ||
| CN102397559A (zh) | 广谱型流感疫苗及其制备方法 | |
| RU2788403C2 (ru) | Мутанты белка f rsv | |
| Samal et al. | https://www. jbc. org/cgi/doi/10.1074/jbc. RA120. 013233 The latest version is at |